Vimta Labs Limited (VIMTALABS) - Net Assets

Latest as of March 2026: Rs4.57 Billion INR ≈ $49.41 Million USD

Based on the latest financial reports, Vimta Labs Limited (VIMTALABS) has net assets worth Rs4.57 Billion INR (≈ $49.41 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs5.62 Billion ≈ $60.80 Million USD) and total liabilities (Rs1.05 Billion ≈ $11.39 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Vimta Labs Limited strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs4.57 Billion
% of Total Assets	81.26%
Annual Growth Rate	7.03%
5-Year Change	95.26%
10-Year Change	235.57%
Growth Volatility	8.64

Vimta Labs Limited - Net Assets Trend (2006–2026)

This chart illustrates how Vimta Labs Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Vimta Labs Limited stock valuation.

Annual Net Assets for Vimta Labs Limited (2006–2026)

The table below shows the annual net assets of Vimta Labs Limited from 2006 to 2026. Also explore VIMTALABS year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2026-03-31	Rs4.57 Billion ≈ $49.41 Million	+20.60%
2025-03-31	Rs3.79 Billion ≈ $40.97 Million	+18.50%
2024-03-31	Rs3.20 Billion ≈ $34.57 Million	+13.45%
2023-03-31	Rs2.82 Billion ≈ $30.47 Million	+20.43%
2022-03-31	Rs2.34 Billion ≈ $25.30 Million	+20.37%
2021-03-31	Rs1.94 Billion ≈ $21.02 Million	+12.44%
2020-03-31	Rs1.73 Billion ≈ $18.70 Million	+0.77%
2019-03-31	Rs1.72 Billion ≈ $18.55 Million	+12.82%
2018-03-31	Rs1.52 Billion ≈ $16.44 Million	+11.68%
2017-03-31	Rs1.36 Billion ≈ $14.72 Million	+7.97%
2016-03-31	Rs1.26 Billion ≈ $13.64 Million	+3.08%
2015-03-31	Rs1.22 Billion ≈ $13.23 Million	+1.61%
2014-03-31	Rs1.20 Billion ≈ $13.02 Million	+7.18%
2013-03-31	Rs1.12 Billion ≈ $12.15 Million	+2.44%
2012-03-31	Rs1.10 Billion ≈ $11.86 Million	-12.30%
2011-03-31	Rs1.25 Billion ≈ $13.52 Million	-4.36%
2010-03-31	Rs1.31 Billion ≈ $14.14 Million	+0.45%
2009-03-31	Rs1.30 Billion ≈ $14.07 Million	+1.54%
2008-03-31	Rs1.28 Billion ≈ $13.86 Million	+3.37%
2007-03-31	Rs1.24 Billion ≈ $13.41 Million	+5.68%
2006-03-31	Rs1.17 Billion ≈ $12.69 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Vimta Labs Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 353221000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2026)

Component	Amount	Percentage
Retained Earnings	Rs3.53 Billion	77.31%
Common Stock	Rs89.34 Million	1.96%
Other Comprehensive Income	Rs137.97 Million	3.02%
Other Components	Rs809.21 Million	17.71%
Total Equity	Rs4.57 Billion	100.00%

Vimta Labs Limited Competitors by Market Cap

The table below lists competitors of Vimta Labs Limited ranked by their market capitalization.

Company	Market Cap
Erdene Resource Development Corp TO:ERD	$289.96 Million
Shenzhen Friendcom Technology Development Co Ltd SHE:300514	$290.03 Million
Hitron Technologies Inc TW:2419	$290.03 Million
Sichuan Golden Summit Group Joint Stock Co Ltd SHG:600678	$290.07 Million
Heung-A Shipping Co. Ltd. KO:003280	$289.53 Million
Daishin Securities Co Ltd Pref KO:003545	$289.53 Million
Hylink Digital Solution Co Ltd SHG:603825	$289.53 Million
HAXC Holdings (Beijing) Co. Ltd. SHE:300928	$289.50 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Vimta Labs Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 3,788,480,000 to 4,568,730,000, a change of 780,250,000 (20.6%).
Net income of 775,120,000 contributed positively to equity growth.
Dividend payments of 44,510,000 reduced retained earnings.
Other comprehensive income increased equity by 5,970,000.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	Rs775.12 Million	+16.97%
Dividends Paid	Rs44.51 Million	-0.97%
Other Comprehensive Income	Rs5.97 Million	+0.13%
Other Changes	Rs43.67 Million	+0.96%
Total Change	Rs-	20.60%

Book Value vs Market Value Analysis

This analysis compares Vimta Labs Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 5.91x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 11.29x to 5.91x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2006-03-31	Rs53.07	Rs599.30	x
2007-03-31	Rs56.08	Rs599.30	x
2008-03-31	Rs57.97	Rs599.30	x
2009-03-31	Rs58.86	Rs599.30	x
2010-03-31	Rs59.13	Rs599.30	x
2011-03-31	Rs56.55	Rs599.30	x
2012-03-31	Rs49.60	Rs599.30	x
2013-03-31	Rs50.81	Rs599.30	x
2014-03-31	Rs54.45	Rs599.30	x
2015-03-31	Rs55.33	Rs599.30	x
2016-03-31	Rs57.04	Rs599.30	x
2017-03-31	Rs61.58	Rs599.30	x
2018-03-31	Rs68.78	Rs599.30	x
2019-03-31	Rs77.60	Rs599.30	x
2020-03-31	Rs78.20	Rs599.30	x
2021-03-31	Rs87.92	Rs599.30	x
2022-03-31	Rs103.72	Rs599.30	x
2023-03-31	Rs124.89	Rs599.30	x
2024-03-31	Rs142.22	Rs599.30	x
2025-03-31	Rs170.35	Rs599.30	x
2026-03-31	Rs101.38	Rs599.30	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Vimta Labs Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 16.97%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 19.03%
• Asset Turnover: 0.72x
• Equity Multiplier: 1.23x
Recent ROE (16.97%) is above the historical average (7.88%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2006	11.51%	24.91%	0.32x	1.46x	Rs17.67 Million
2007	7.04%	15.24%	0.33x	1.40x	Rs-36.71 Million
2008	4.87%	8.14%	0.44x	1.35x	Rs-65.70 Million
2009	3.11%	4.96%	0.48x	1.30x	Rs-89.69 Million
2010	2.03%	3.06%	0.48x	1.39x	Rs-104.14 Million
2011	-3.73%	-4.87%	0.54x	1.41x	Rs-171.68 Million
2012	-14.02%	-17.60%	0.56x	1.43x	Rs-263.41 Million
2013	3.75%	3.86%	0.75x	1.29x	Rs-70.19 Million
2014	11.00%	11.19%	0.79x	1.24x	Rs12.01 Million
2015	4.14%	4.72%	0.73x	1.20x	Rs-71.71 Million
2016	5.10%	5.16%	0.71x	1.39x	Rs-61.76 Million
2017	7.78%	6.88%	0.69x	1.63x	Rs-30.23 Million
2018	10.81%	8.96%	0.79x	1.53x	Rs12.28 Million
2019	14.75%	11.90%	0.90x	1.38x	Rs81.56 Million
2020	3.96%	3.79%	0.74x	1.42x	Rs-104.43 Million
2021	11.01%	10.26%	0.76x	1.41x	Rs19.67 Million
2022	17.66%	14.98%	0.90x	1.31x	Rs179.32 Million
2023	17.10%	15.29%	0.87x	1.29x	Rs199.93 Million
2024	12.83%	12.89%	0.80x	1.25x	Rs90.39 Million
2025	17.78%	19.58%	0.74x	1.23x	Rs294.57 Million
2026	16.97%	19.03%	0.72x	1.23x	Rs318.25 Million

Industry Comparison

This section compares Vimta Labs Limited's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

Industry: Diagnostics & Research
Average net assets among peers: $7,730,053,000
Average return on equity (ROE) among peers: 20.02%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Vimta Labs Limited (VIMTALABS)	Rs4.57 Billion	11.51%	0.23x	$289.62 Million
Krsnaa Diagnostics Limited (KRSNAA)	$8.83 Billion	8.79%	0.45x	$192.40 Million
Dr. Lal Path Labs Ltd. (LALPATHLAB)	$25.41 Billion	19.86%	0.24x	$3.53 Billion
Metropolis Healthcare Limited (METROPOLIS)	$3.44 Billion	29.54%	0.50x	$326.57 Million
Syngene International Limited (SYNGENE)	$2.21 Billion	12.32%	1.28x	$1.65 Billion
Thyrocare Technologies Limited (THYROCARE)	$1.02 Billion	34.10%	0.34x	$975.70 Million
Vijaya Diagnostic Centre Limited (VIJAYA)	$5.47 Billion	15.48%	0.56x	$1.69 Billion

About Vimta Labs Limited

NSE:VIMTALABS India Diagnostics & Research

Market Cap

$289.62 Million

Rs26.78 Billion INR

Market Cap Rank

#15110 Global

#762 in India

Share Price

Rs599.30

Change (1 day)

+0.30%

52-Week Range

Rs380.70 - Rs748.20

All Time High

Rs1155.00